We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$158M
Cap. Flow %
6.35%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.1 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.99%
2 Technology 15.91%
3 Financials 8.1%
4 Healthcare 5.94%
5 Consumer Discretionary 5.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MTUS icon
3276
Metallus
MTUS
$857M
$0 ﹤0.01%
18
-39
-68% -$534
2021 Q2
1 quarter
QTTB icon
3277
Q32 Bio
QTTB
$238M
$0 ﹤0.01%
1
– –
2021 Q2
1 quarter
TRAW icon
3278
Traws Pharma
TRAW
$6.17M
$0 ﹤0.01%
+1
New +$129
2021 Q3
0 quarters
RPT icon
3279
Rithm Property Trust
RPT
$82.7M
$0 ﹤0.01%
5
– –
2020 Q2
5 quarters
INVX icon
3280
Innovex International
INVX
$1.95B
– –
-65
Closed -$2K –
HTB icon
3281
HomeTrust Bancshares
HTB
$759M
– –
-205
Closed -$6K –
NAGE icon
3282
Niagen Bioscience
NAGE
$200M
– –
-100
Closed -$1K –
HYB
3283
DELISTED
New America High Income Fund, Inc.
HYB
$0 ﹤0.01%
1
– –
2018 Q2
13 quarters
SCWX icon
3284
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
– –
-1
Closed – –
VIRX icon
3285
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$0 ﹤0.01%
8
– –
2018 Q4
11 quarters
GATO
3286
DELISTED
Gatos Silver, Inc.
GATO
– –
-54
Closed -$1K –
AKTS icon
3287
DELISTED
Akoustis Technologies Inc
AKTS
$0 ﹤0.01%
35
– –
2020 Q4
3 quarters
TCS icon
3288
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
– –
-71
Closed -$14K –
RCM icon
3289
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-4
Closed – –
AXNX icon
3290
DELISTED
Axonics, Inc. Common Stock
AXNX
$0 ﹤0.01%
+4
New +$273
2021 Q3
0 quarters
MKFG.WS icon
3291
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$0 ﹤0.01%
+250
New +$404
2021 Q3
0 quarters
AMK icon
3292
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$0 ﹤0.01%
+8
New +$206
2021 Q3
0 quarters
CONN icon
3293
DELISTED
Conn's Inc.
CONN
$0 ﹤0.01%
+19
New +$451
2021 Q3
0 quarters
MCBC icon
3294
DELISTED
Macatawa Bank Corp
MCBC
$0 ﹤0.01%
31
+1
+3% +$8
2020 Q2
5 quarters
EFTR icon
3295
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
– –
-10
Closed -$2K –
BIOL icon
3296
DELISTED
Biolase, Inc.
BIOL
– –
0
– –
2021 Q3
0 quarters
THMO icon
3297
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
– –
0
– –
2019 Q2
9 quarters
NURO icon
3298
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$0 ﹤0.01%
+1
New +$89
2021 Q3
0 quarters
SP icon
3299
DELISTED
SP Plus Corporation
SP
– –
-32
Closed -$1K –
AFIB icon
3300
DELISTED
Acutus Medical Inc
AFIB
$0 ﹤0.01%
+12
New +$158
2021 Q3
0 quarters

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.